These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4229628)

  • 21. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 22. [The fibrinolytic system in the postoperative phase and its importance in normal and disturbed wound healing].
    Woziwodzki G
    Zentralbl Chir; 1967; 92(26a Pt 1):1086-90. PubMed ID: 4232849
    [No Abstract]   [Full Text] [Related]  

  • 23. [The fibrinolytic activity in Seegers' cattle prothrombin preparations. A contribution to the problem of the activation of cattle prothrombin by plasmin].
    Andrassy K; Egbring R; Egli H
    Thromb Diath Haemorrh; 1969 Nov; 22(2):377-90. PubMed ID: 4245334
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibrinolysis in human foetuses.
    Ekelund H; Hedner U; Astedt B
    Acta Paediatr Scand; 1970 Jul; 59(4):369-76. PubMed ID: 4247258
    [No Abstract]   [Full Text] [Related]  

  • 25. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation in assays of standard SK and plasmin preparations: evidence for and effect of variability of plasmins, plasminogen, and fibrinogen.
    Johnson AJ; Tse A; Skoza L
    Fed Proc; 1966; 25(1):34-41. PubMed ID: 4283648
    [No Abstract]   [Full Text] [Related]  

  • 27. Profibrinolysin, antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject.
    GUEST MM
    J Clin Invest; 1954 Nov; 33(11):1553-9. PubMed ID: 13211809
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of venous occlusion on coagulation and fibrinolytic components in normal subjects.
    Nilsson IM; Robertson B
    Thromb Diath Haemorrh; 1968 Dec; 20(3):397-408. PubMed ID: 5710462
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The significance of fibrinolysis in abortion.
    Soma H
    Zasshi Tokyo Ika Daigaku; 1970 Mar; 28(2):343-50. PubMed ID: 4260254
    [No Abstract]   [Full Text] [Related]  

  • 31. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [So-called essential renal hematuria and fibrinolytic enzyme system].
    Manabe H
    Hinyokika Kiyo; 1971 May; 17(5):314-29. PubMed ID: 4253913
    [No Abstract]   [Full Text] [Related]  

  • 33. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity.
    Hedner U; Nilsson IM; Jacobsen CD
    Scand J Clin Lab Invest; 1970 Jun; 25(4):329-36. PubMed ID: 4247664
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrinolytic components of human uterine arterial and venous blood.
    Mackay AV; Das PC; Myerscough PR; Cash JD
    J Clin Pathol; 1967 May; 20(3):227-30. PubMed ID: 5602553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinolytic activity of veins in the puerperium.
    Astedt B
    Acta Obstet Gynecol Scand; 1972; 51(4):325-8. PubMed ID: 4642719
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of myocardial infarction on components of fibrinolytic system.
    Gidron E; Margalit R; Oliven A; Shalitin Y
    Br Heart J; 1977 Jan; 39(1):19-24. PubMed ID: 137732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproducibility in coagulation assays.
    Goldenfarb PB
    Am J Clin Pathol; 1971 May; 55(5):561-4. PubMed ID: 4253630
    [No Abstract]   [Full Text] [Related]  

  • 38. [Essential hyperlipemia and decreased fibrinolysis activity].
    Spöttl F; Holzknecht F; Braunsteiner H
    Acta Haematol; 1967; 38(3):180-3. PubMed ID: 4963585
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of bioresolving microspheric preparations of immobilized fibrinolysin on the fibrinolysis system].
    Bessolitsyna LA; Mazaev AB; Markosian RA; Suvorov AV; Torchilin VP
    Biull Eksp Biol Med; 1980; 89(1):16-8. PubMed ID: 6445763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinolytic activity in alveoli after tooth extraction.
    Björlin G; Nilsson IM
    Odontol Revy; 1968; 19(2):197-204. PubMed ID: 4235501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.